The Novel Oncolytic Compound LTX-401 Induces Antitumor Immune Responses in Experimental Hepatocellul...
The Novel Oncolytic Compound LTX-401 Induces Antitumor Immune Responses in Experimental Hepatocellular Carcinoma
About this item
Full title
The Novel Oncolytic Compound LTX-401 Induces Antitumor Immune Responses in Experimental Hepatocellular Carcinoma
Author / Creator
Journal title
Molecular therapy. Oncolytics, 2019
Language
Norwegian
Formats
More information
Scope and Contents
Contents
LTX-401 is a novel oncolytic compound designed for the local treatment of solid tumors. In the present study, we have examined the applicability and efficacy of LTX-401 in a rat model JM1 hepatocellular carcinoma, with particular interest in its ability to induce antitumor immunity. LTX-401 induces necrotic cell death followed by the release of imm...
Alternative Titles
Full title
The Novel Oncolytic Compound LTX-401 Induces Antitumor Immune Responses in Experimental Hepatocellular Carcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_cristin_nora_10852_73926
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_cristin_nora_10852_73926
Other Identifiers
ISSN
2372-7705
E-ISSN
2372-7705
How to access this item
Log in as a Library member
